5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 14.64▲ | 14.59▲ | 14.61▲ | 14.78▼ | 13.50▲ |
MA10 | 14.60▲ | 14.60▲ | 14.63▲ | 14.54▲ | 11.71▲ |
MA20 | 14.59▲ | 14.65▲ | 14.71▲ | 13.58▲ | 10.39▲ |
MA50 | 14.58▲ | 14.74▲ | 14.85▼ | 11.44▲ | 10.30▲ |
MA100 | 14.61▲ | 14.80▼ | 14.22▲ | 10.16▲ | 12.46▲ |
MA200 | 14.71▲ | 14.11▲ | 12.74▲ | 9.68▲ | 10.41▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.019▲ | 0.010▲ | -0.011▼ | 0.006▲ | 0.715▲ |
RSI | 70.496▲ | 56.091▲ | 52.441▲ | 72.055▲ | 73.678▲ |
STOCH | 85.126▲ | 46.500 | 45.756 | 67.535 | 86.560▲ |
WILL %R | 0.000▲ | 0.000▲ | -36.508 | -30.220 | -11.676▲ |
CCI | 280.631▲ | 160.580▲ | -6.422 | 43.532 | 154.040▲ |
Tuesday, August 26, 2025 09:36 PM
Avadel Pharmaceuticals PLC stock grades by Barron's. View AVDL fundamental and sentiment analysis powered by MarketGrader.
|
Thursday, August 07, 2025 07:30 AM
Avadel Pharmaceuticals Plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to improve lives, released its earnings for Q2 2025 on August 7, 2025.
|
Monday, May 12, 2025 10:37 AM
Avadel (AVDL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
29/08/25 | 14.76 | 14.77 | 14.362 | 14.76 | 1,646,230 |
28/08/25 | 14.89 | 14.99 | 14.52 | 14.62 | 1,034,806 |
27/08/25 | 14.85 | 14.93 | 14.53 | 14.87 | 1,064,279 |
26/08/25 | 14.89 | 14.97 | 14.66 | 14.85 | 1,325,594 |
25/08/25 | 15.27 | 15.53 | 14.745 | 14.81 | 1,369,749 |
22/08/25 | 14.90 | 15.585 | 14.85 | 15.24 | 1,554,906 |
21/08/25 | 14.64 | 14.905 | 14.325 | 14.82 | 1,615,559 |
20/08/25 | 13.57 | 14.33 | 13.57 | 14.25 | 1,095,123 |
19/08/25 | 13.50 | 13.705 | 13.44 | 13.70 | 720,478 |
18/08/25 | 13.83 | 13.91 | 13.40 | 13.48 | 888,926 |
|
|
||||
|
|
||||
|
|